Alaunos Therapeutics Inc (TCRT)

Jun 18, 2025

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading Wall Street Bank Behind Many Leading Crypto Strategies - The Manila Times

Jun 18, 2025

Jun 18, 2025

PMGC Capital Urges Alaunos Therapeutics to Accept Strategic Financing Opportunity - Nasdaq

Jun 18, 2025

Jun 18, 2025

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) - GlobeNewswire

Jun 18, 2025

Jun 18, 2025

PMGC Capital LLC Urges Alaunos Therapeutics (NASDAQ: TCRT) to Accept Term Sheet from Leading - Bluefield Daily Telegraph

Jun 18, 2025

Jun 18, 2025

Clean Financing Deal: Top Wall Street Bank Backs Alaunos While Major Investor PMGC Capital Demands Action - Stock Titan

Jun 18, 2025

Jun 10, 2025

Alaunos Therapeutics Amends Warrant Agreement with Mast Hill - TipRanks

Jun 10, 2025

Jun 06, 2025

Alaunos Therapeutics Secures $25M Equity Purchase Deal - MSN

Jun 06, 2025

Jun 06, 2025

Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Short Interest Update - Defense World

Jun 06, 2025

May 16, 2025

Ziopharm: Q1 Earnings Snapshot - CT Insider

May 16, 2025

May 16, 2025

Alaunos Therapeutics (NASDAQ:TCRT) Trading Down 2.4% – Time to Sell? - Defense World

May 16, 2025

May 14, 2025

PMGC Capital announces filing to report 5.09% stake in Alaunos Therapeutics - TipRanks

May 14, 2025

May 14, 2025

PMGC Capital LLC, a Subsidiary of PMGC Holdings Inc. - GlobeNewswire

May 14, 2025

May 14, 2025

PMGC Capital Takes 5.09% Stake in Alaunos Therapeutics, Eyes Strategic Changes Including Fintech Expansion - Stock Titan

May 14, 2025

Apr 24, 2025

Alaunos Therapeutics (NASDAQ:TCRT) Trading Up 2.5% – Time to Buy? - Defense World

Apr 24, 2025

Apr 18, 2025

Alaunos Therapeutics announces board member resignation - Investing.com Australia

Apr 18, 2025

Apr 18, 2025

Alaunos Therapeutics announces board member resignation By Investing.com - Investing.com Canada

Apr 18, 2025

Apr 16, 2025

Form 8-KCurrent report - ADVFN

Apr 16, 2025

Apr 15, 2025

Alaunos Therapeutics Board Opts for Equity Compensation - TipRanks

Apr 15, 2025

Apr 14, 2025

Alaunos Therapeutics announces private placement of preferred stock By Investing.com - Investing.com Canada

Apr 14, 2025

Apr 14, 2025

Alaunos Therapeutics announces private placement of preferred stock - Investing.com

Apr 14, 2025

Apr 04, 2025

Alaunos Therapeutics And 2 Other Promising Penny Stocks To Watch - simplywall.st

Apr 04, 2025

Apr 04, 2025

Alaunos Therapeutics, Inc. (NASDAQ:TCRT) Short Interest Down 12.5% in March - Defense World

Apr 04, 2025

Apr 03, 2025

11 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Apr 03, 2025

Apr 02, 2025

12 Health Care Stocks Moving In Wednesday's Intraday SessionAllakos (NASDAQ:ALLK), Alumis (NASDAQ:ALMS) - Benzinga

Apr 02, 2025

Apr 01, 2025

12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga

Apr 01, 2025

Mar 31, 2025

Alaunos Therapeutics Inc. (TCRT) reports earnings - Quartz

Mar 31, 2025

Mar 27, 2025

Alaunos Therapeutics (NASDAQ:TCRT) Shares Down 6.5% – Here’s What Happened - Defense World

Mar 27, 2025

Jan 29, 2025

Lantheus acquires radiopharma CDMO Evergreen for up to $1bn - Pharmaceutical Technology

Jan 29, 2025

Jan 15, 2025

Alaunos Therapeutics (NASDAQ:TCRT) Stock Price Up 4% – Should You Buy? - Defense World

Jan 15, 2025

Jan 13, 2025

Update: Johnson & Johnson acquires Intra-Cellular Therapies - Pharmaceutical Technology

Jan 13, 2025

Jan 10, 2025

Light Horse emerges with $62m and Novartis partnership worth up to $1bn - Pharmaceutical Technology

Jan 10, 2025

Dec 24, 2024

Alaunos Therapeutics (NASDAQ:TCRT) Stock Price Down 0.5% – Time to Sell? - Defense World

Dec 24, 2024

Dec 13, 2024

TCRT stock touches 52-week low at $1.92 amid market challenges - Investing.com

Dec 13, 2024

Nov 22, 2024

Novartis acquires Kate Therapeutics to advance gene therapies - Pharmaceutical Technology

Nov 22, 2024

Nov 14, 2024

Alaunos Therapeutics, Inc. SEC 10-Q Report - TradingView

Nov 14, 2024

Oct 11, 2024

Alaunos Therapeutics Ends Licensing Deal, Reassesses Strategy - Yahoo Finance

Oct 11, 2024

Oct 10, 2024

Precigen Terminates License Agreement With Alaunos Therapeutics - MarketWatch

Oct 10, 2024

Oct 01, 2024

Genentech buys Regor’s CDK inhibitors in $850m deal - Clinical Trials Arena

Oct 01, 2024

Aug 23, 2024

VION Biosciences acquires Echelon Biosciences - Pharmaceutical Technology

Aug 23, 2024

Aug 17, 2024

TCRT stock touches 52-week low at $2.28 amid market challenges - Investing.com India

Aug 17, 2024

Aug 14, 2024

Eli Lilly inaugurates R&D facility in Boston, US - Pharmaceutical Technology

Aug 14, 2024

Jul 16, 2024

Alaunos Therapeutics announces 1-for-10 reverse stock split - Investing.com

Jul 16, 2024

Mar 27, 2024

Avenzo Therapeutics secures $150m to bolster oncology pipeline - Pharmaceutical Technology

Mar 27, 2024

Mar 25, 2024

Gilead concludes acquisition of CymaBay Therapeutics for $4.3bn - Pharmaceutical Technology

Mar 25, 2024

Jan 30, 2024

Alaunos Therapeutics Announces 1-for-15 Reverse Stock Split - TipRanks

Jan 30, 2024

Jan 25, 2024

Kyowa Kirin acquires Orchard Therapeutics for $477.6m - Pharmaceutical Technology

Jan 25, 2024

Jan 24, 2024

NAYA buys gene therapy company Florida Biotech for $20m - Clinical Trials Arena

Jan 24, 2024

Jan 23, 2024

Genentech signs nanoparticle deal worth up to $644m with GenEdit - Pharmaceutical Technology

Jan 23, 2024

Jan 04, 2024

BridGene and Galapagos partner for oncology drugs discovery - Pharmaceutical Technology

Jan 04, 2024

Jan 03, 2024

Novartis allies with Voyager to develop gene therapies in $1.3bn deal - Pharmaceutical Technology

Jan 03, 2024

Nov 24, 2023

ELABPMGC Holdings Latest Stock News & Market Updates - Stock Titan

Nov 24, 2023

Nov 24, 2023

ELEVAI Labs, Inc. Announces Closing of $6,000,000 Initial Public Offering - Stock Titan

Nov 24, 2023

Nov 14, 2023

Why Is Alaunos Therapeutics (TCRT) Stock Up 14% Today? - InvestorPlace

Nov 14, 2023

Nov 09, 2023

Ascidian Therapeutics raises $40m to advance drug development - Pharmaceutical Technology

Nov 09, 2023

Nov 01, 2023

AstraZeneca and Cellectis partner to advance cell and gene therapies - Pharmaceutical Technology

Nov 01, 2023